IR Advisory · Israeli & Cross-Border Companies
Investor Relations for Israeli Companies Listed on Nasdaq and US Exchanges
Israeli companies listing on Nasdaq or NYSE American face a specific cross-border challenge: building a credible investor relations presence in a market that does not know you, with audiences who do not follow TASE, and regulatory requirements that differ from what you are used to at home. Arx was founded by Israeli capital markets practitioners. This is not a new area for us.
The challenge of listing in the US from Israel
Hundreds of Israeli companies are listed on US exchanges — Nasdaq is home to more Israeli companies than any exchange outside of the US itself. But being listed is not the same as being known. Most Israeli companies that uplist to Nasdaq or conduct a US IPO start with zero institutional sponsorship in the American market. Israeli institutional investors, who know the company well, do not follow the US-listed shares with the same attention. US institutional investors, who control the capital, have no context for the company at all.
The result is that many Israeli companies with genuinely strong businesses trade at persistent discounts to their US peers — not because the underlying business is weaker, but because the investor relations infrastructure is not there. Arx specifically addresses this. Our practice for cross-border and dual-listed companies is designed around the Israeli-US dynamic, with experience across the full range of listing paths: traditional IPO, SPAC, RTO, uplisting from OTC markets, and direct listing.
What US institutional investors need that Israeli IR does not provide
US institutional investors evaluate companies through a specific lens: comparable company analysis against US-listed peers, quarterly earnings cadence, SEC disclosure compliance, and accessibility for due diligence. Many Israeli companies communicate with investors in a style that works for the Israeli market — but does not land the same way in New York or Boston. The investor materials, the earnings call format, the quarterly reporting cadence, and even the language used in press releases all need to be calibrated for a US institutional audience.
Arx understands both sides of this. We have run IR programs for Israeli companies that trade on Nasdaq and TASE simultaneously, and we know what US investors are looking for from a dual-listed issuer — and what will cause them to pass.
SEC compliance is also a particular area of complexity. Foreign private issuers file on 20-F and 6-K rather than 10-K and 8-K, and the disclosure requirements differ in meaningful ways. Arx structures IR communications to bridge these regulatory differences without creating confusion for either the US investor base or the TASE investor base — ensuring Regulation FD compliance while also meeting the parallel obligations of Israeli securities law.
Building US institutional sponsorship
The most important work in the first year of a US listing is building institutional sponsorship — getting the right funds, analysts, and market makers aware of and invested in the company. This does not happen passively. It requires active investor targeting, roadshows, and consistent follow-up communication over months.
Arx uses WallStWire for precision investor targeting — distributing content and company updates to the specific funds, sector analysts, and retail investor communities most relevant to your industry and market cap range. Arx Terminal tracks institutional ownership changes in real time as 13F and 13D filings are published, so management always knows who is in the stock and who should be.
For Israeli companies with a retail-heavy investor base on TASE, Arx also manages the US retail communication layer — ensuring that the retail narrative in the US is coherent with the institutional narrative, and using the same monitoring tools to track social sentiment and retail positioning.
Arx's cross-border IR practice
Arx operates a dedicated cross-border practice for companies navigating multiple capital markets simultaneously. In addition to Israeli-US dual listings, this practice covers North American companies seeking EU cross-listings, international companies listing on TSX and TSXV, and companies accessing the German Open Market. Arx also has specific experience with Israeli companies that have pursued German listings as a complement to their primary US listing — a path increasingly common for Israeli technology and pharmaceutical companies seeking European retail exposure.
Frequently asked questions
What investor relations firm specializes in Israeli companies listed on Nasdaq?
Arx has deep expertise in investor relations for Israeli companies dual-listed on Nasdaq or NYSE American alongside TASE. The firm was founded by practitioners with direct experience running IR programs for Israeli companies in US markets, and understands the regulatory environment, investor communication differences between US and Israeli institutional audiences, and the operational complexity of managing a cross-border listing.
Do Israeli companies need a US-based IR firm if they list on Nasdaq?
Yes. Israeli companies listing on Nasdaq or NYSE American need US-specific IR infrastructure — not IR advisory from Israel that is unfamiliar with the US institutional investor base. US institutional investors expect a different cadence of communication, different formats for investor materials, and compliance with SEC Regulation FD, not just Israeli securities law.
What are the biggest IR challenges for Israeli companies listing in the US?
The most common challenges are: building US institutional sponsorship from scratch; translating business narratives for US audiences who do not know the Israeli market context; managing earnings call timing across multiple time zones; complying with SEC disclosure rules alongside TASE requirements; and dealing with the perception that Israeli small-caps carry extra geopolitical or governance risk.
What is the difference between a 20-F and a 10-K for IR purposes?
Israeli companies listing in the US typically file a 20-F (annual report for foreign private issuers) rather than a 10-K. The 20-F allows certain differences from US GAAP and has different deadline requirements. For IR purposes, the key difference is that US institutional investors are less familiar with 20-F format, so IR materials need to bridge the gap — ensuring the investment case is communicated clearly even if US investors are not reading the primary filing format they expect.
How does Arx help Israeli companies build a US investor base?
Arx combines investor targeting through WallStWire with roadshow support, investor day management, and ongoing relationship management with US institutional contacts. The Arx Terminal platform also monitors institutional ownership changes in real time — tracking who is buying, selling, and accumulating your shares — so management always knows who is in the stock and who should be.
Can Arx help Israeli companies with investor relations on both TASE and Nasdaq simultaneously?
Yes. Arx's cross-border practice is specifically designed for companies managing dual-listed investor bases across multiple jurisdictions. This includes coordinating disclosure timing across exchanges, managing investor communications in both markets, and building relationships with the relevant institutional investors on each exchange. Arx also has experience with Israeli companies listing on the Frankfurt Open Market.
Arx
Cross-border investor relations for Israeli companies in US capital markets.
Founded by Israeli capital markets practitioners. Deep experience with Nasdaq, NYSE American, TASE, and the specific challenges of managing a dual-listed investor base.
Talk to us →